MSLP Financials 07/15/2014 23:27:19 MusclePharm C

MSLP Financials 07/15/2014 23:27:19
MusclePharm Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 110,878 67,055 17,213 3,203
Cost of Revenue 77,685 52,727 14,845 2,804
Gross Profit 33,192 14,328 2,368 398
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 47,489 23,064 18,588 18,650
Non-Recurring Items - - - -
Other - - - -
Operating Income (14,296) (8,736) (16,220) (18,252)
Income From Continuing Operations
Add'l Income/Expense Items (2,523) (2,882) (3,350) (837)
Earnings Before Interest and Tax (16,819) (11,618) (19,570) (19,089)
Interest Expense 783 7,335 3,711 481
Earnings Before Tax (17,602) (18,953) (23,281) (19,569)
Income Tax 115 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (17,718) (18,953) (23,281) (19,569)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (17,718) (18,953) (23,281) (19,569)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (17,718) (18,953) (23,281) (19,569)